FDA is one of those agencies that seems to retain a good reputation—outside the realm of people who are actually familiar with how it works. For most who have had the misfortune to deal with it, it is widely despised.
This article delves into the frankly horrific story of diabetes meds, and then segues into FDA's latest failure—the endoscope-related infections. In a sense, this is failure beyond failure, since FDA was finally starting to kick some butt in this affair, only to completely back off.
For an agency that STILL touts its thalidomide victory form the ealry 1960s (while keeping quite silent on the matter of American thalidomide babies), it's time for big changes.
Read the complete article.